Study gives more insight into immunotherapy treatment for ALS

A type of monoclonal antibody that has already been tried in certain types of cancer may be a viable treatment for...

Dupilumab reduces disease in COPD patients: Study

Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in...

Clinical use of antibodies m cause fungal infections: Study

Researchers found some monoclonal antibodies used in clinical trials have been linked to life-threatening systemic...

Early RSV infection associated to risk of asthma in children

The development of childhood wheezing illnesses has long been linked to severe respiratory syncytial virus (RSV)...

Immunotherapy could be effective for treatment of prostate cancer

According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive...

Novel immunotherapy helps fight against high-risk prostate cancer

According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive...

Researchers discover biomarker method to diagnose heart problems

Researchers at Michigan Medicine have developed a new biomarker-based technique to screen for a rare and fatal...

Research finds how antibody therapy impacts COVID vaccines

Nearly three years into the pandemic, many of us now carry antibodies against the virus--due to an infection or two,...

New treatment for atopic dermatitis shows promising result

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel,...

Anifrolumab has shown long-term efficiency in lupus patients

Type I interferon (IFN) is a strong immune activator found in high concentrations in the majority of patients with...

Scientists discover new drug to lower symptoms of severe eczema

Illinois [US], September 24 (ANI): Researchers from Northwestern Medicine discovered a new drug that was highly...

New drug helps relieve eczema's terrible itch

Illinois [US], September 19 (ANI): Researchers involved in a new multi-site international phase III study led by...